Neurology
RSSArticles
-
Full September 29, 2004, Issue in PDF
-
Pharmacology Update: Duloxetine Hydrochloride Capsules (Cymbalta)
The FDA has approved duloxetine for the treatment of depression and the management of the pain associated with diabetic peripheral neuropathy. -
Clinical Briefs in Primary Care supplement
-
Understanding Immune Regulation in Multiple Sclerosis
NK cells may regulate activation of autoimmune memory T cells in an antigen non-specific fashion to maintain the clinical remission in CD95(+) NK-high multiple sclerosis patients. -
Correction
-
Full August 29, 2004, Issue in PDF
-
Optimal Frequency of BNP Testing
At this time, BNP seems to be a useful initial test that should not be repeated during short hospital stays. -
Hyperkalemia Risk Alert in Managing Heart Failure
Patients treated with spironolactone and ACE inhibitors for congestive heart failure have a markedly increased risk of hyperkalemia. -
Statins and Cancer Protection
In an observational study, enabled by a powerful drug-dispensing record linkage system, statin use among a large number of patients treated with cardiovascular drugs was associated with a 20% reduction in incipient cancer diagnosis over a 7-year period. -
Pharmacology Watch: Importance of Publishing Negative Clinical Studies
Sources of funding for pharmaceutical research has come under scrutiny in the last decade as academic and government sources of funding have become increasingly scarce and the pharmaceutical industry has become the main source of research dollars. But the issue of objectivity has been raised, and some have even suggested that negative studies, that is studies that show a drug in an unfavorable light, may never be published. The American Medical Association has recently tackled this issue.